about
Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancersUnbiased and automated identification of a circulating tumour cell definition that associates with overall survivalLinked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study.Mendelian Randomisation study of the influence of eGFR on coronary heart disease.A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.Factors Associated with Greater Adherence to and Satisfaction with Transdermal Rivastigmine in Patients with Alzheimer's Disease and Their Caregivers.Design optimization for clinical trials in early-stage manifest Huntington's disease.The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies.Classifying atopic dermatitis: protocol for a systematic review of subtypes (phenotypes) and associated characteristicsDoes depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trialsClinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate CancerHow the EMERGE guideline on medication adherence can improve the quality of clinical trialsIs improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials
P50
Q28484970-B5FD0E0B-779C-4A4D-9772-41CC1BC85D0BQ28743067-35ED9A6A-842B-4C91-9C4F-F2E2462E3DCCQ38695285-A50CF7F3-75DB-4E10-95F2-F87B42ABEFB6Q38939614-57172CD7-7F40-4DE2-AF87-D22556BD06D7Q39532016-54E0C437-AF58-4850-A696-004434615D00Q40844307-C4F4459E-F009-46BD-82D5-35E21445EB9FQ45304194-CD7DF3F8-8CF2-4A8F-A85F-4518AF605DAAQ52633024-BAE188C3-BE34-40E4-A2D9-EFC35A28B312Q58068226-F3083727-92DC-4F78-BC3F-059FC7C76967Q58068236-02DF1573-BB02-4683-A98A-7CDCC108AF70Q58068307-87B388D6-DF45-4289-A9DA-C495061467FAQ89605838-A48DB8FC-DDCF-4F90-B20A-7154C38BF980Q91096779-1CD45A68-FC63-4128-98BE-8D5713319DF7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amy Mulick Cassidy
@ast
Amy Mulick Cassidy
@en
Amy Mulick Cassidy
@es
Amy Mulick Cassidy
@nl
type
label
Amy Mulick Cassidy
@ast
Amy Mulick Cassidy
@en
Amy Mulick Cassidy
@es
Amy Mulick Cassidy
@nl
prefLabel
Amy Mulick Cassidy
@ast
Amy Mulick Cassidy
@en
Amy Mulick Cassidy
@es
Amy Mulick Cassidy
@nl
P106
P1153
57194699951
P31
P496
0000-0002-4009-2080